The role of glia in retinal vascular disease

被引:104
|
作者
Coorey, Nathan J. [1 ]
Shen, Weiyong [1 ]
Chung, Sook H. [1 ]
Zhu, Ling [1 ]
Gillies, Mark C. [1 ]
机构
[1] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
age‐ related macular degeneration; astrocytes; diabetic retinopathy; glia; Mü ller cells; retina; retinopathy of prematurity; vascular disease; ENDOTHELIAL GROWTH-FACTOR; OPTICAL COHERENCE TOMOGRAPHY; FIBRILLARY ACIDIC PROTEIN; MACULAR TELANGIECTASIA TYPE-2; EPITHELIUM-DERIVED FACTOR; NITRIC-OXIDE SYNTHASE; MULLER CELLS; DIABETIC-RETINOPATHY; PHOTORECEPTOR DEGENERATION; INTRAVITREAL BEVACIZUMAB;
D O I
10.1111/j.1444-0938.2012.00741.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Retinal vascular diseases collectively represent a leading cause of blindness. Unsurprisingly, pathological characterisation and treatment of retinal 'vascular' diseases have primarily focused on the aetiology and consequences of vascular dysfunction. Far less research has addressed the contribution of neuronal and glial dysfunction to the disease process of retinal vascular disorders. Ample evidence now suggests that retinal vasculopathy only uncommonly occurs in isolation, usually existing in concert with neuropathy and gliopathy. Retinal glia (Muller cells, astrocytes and microglia) have been reported to exhibit morphological and functional changes in both early and advanced phases of almost every retinal vascular disease. It is anticipated that identifying the causes of glial activation and dysfunction, and their contribution to loss of vision in retinal vascular disease, will lead to a better understanding of retinal vascular diseases, which might ultimately be translated into novel clinical therapies.
引用
收藏
页码:266 / 281
页数:16
相关论文
共 50 条
  • [41] Vascular Endothelial Growth Factor and Diabetic Retinal Disease
    Ajlan, Radwan S.
    Silva, Paolo S.
    Sun, Jennifer K.
    SEMINARS IN OPHTHALMOLOGY, 2016, 31 (1-2) : 40 - 48
  • [42] The "Neuro-Glial-Vascular" Unit: The Role of Glia in Neurovascular Unit Formation and Dysfunction
    Kugler, Elisabeth C.
    Greenwood, John
    MacDonald, Ryan B.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [43] Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases
    Campochiaro, Peter A.
    Akhlaq, Anam
    PROGRESS IN RETINAL AND EYE RESEARCH, 2021, 83
  • [44] Cytokine determination from vitreous samples in retinal vascular diseases
    Pfister, M.
    Koch, F. H.
    Cinatl, J.
    Rothweiler, F.
    Schubert, R.
    Singh, P.
    Ackermann, H.
    Koss, M. J.
    OPHTHALMOLOGE, 2013, 110 (08): : 746 - 754
  • [45] Translational research in retinal vascular disease. An approach
    Bek, Toke
    ACTA OPHTHALMOLOGICA, 2019, 97 (05) : 441 - 450
  • [46] Telemedicine Applications in Pediatric Retinal Disease
    Pathipati, Akhilesh S.
    Moshfeghi, Darius M.
    JOURNAL OF CLINICAL MEDICINE, 2017, 6 (04):
  • [47] Reprogramming Muller Glia to Regenerate Retinal Neurons
    Lahne, Manuela
    Nagashima, Mikiko
    Hyde, David R.
    Hitchcock, Peter F.
    ANNUAL REVIEW OF VISION SCIENCE, VOL 6, 2020, 2020, 6 : 171 - 193
  • [48] The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications
    Kuter, Katarzyna Z.
    Cenci, M. Angela
    Carta, Anna R.
    RECENT ADVANCES IN PARKINSON'S DISEASE, 2020, 252 : 131 - 168
  • [49] The retinal tyrosine kinome of diabetic Akimba mice highlights potential for specific Src family kinase inhibition in retinal vascular disease
    Sergeys, Jurgen
    Van Hove, Inge
    Hu, Tjing-Tjing
    Temps, Carolin
    Carragher, Neil O.
    Unciti-Broceta, Asier
    Feyen, Jean H. M.
    Moons, Lieve
    Porcu, Michael
    EXPERIMENTAL EYE RESEARCH, 2020, 197
  • [50] The role of extracellular matrix in retinal vascular development and preretinal neovascularization
    Bishop, Paul N.
    EXPERIMENTAL EYE RESEARCH, 2015, 133 : 30 - 36